A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age

Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia

NCT03626727 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime Sleepiness

NCT01124851 ·Status: COMPLETED ·Phase: PHASE1

Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder

NCT00758498 ·Status: COMPLETED ·Phase: PHASE3

Lemborexant Shift Work Treatment Study

NCT05344443 ·Status: COMPLETED ·Phase: PHASE4

Pharmacodynamic Profile of SPD489 in Healthy Adult Males Undergoing a Nocturnal Period of Acute Sleep Loss

NCT01096680 ·Status: COMPLETED ·Phase: PHASE2

Treating Insomnia and Improving Metabolic Health in Midlife Women With Insomnia

NCT05593653 ·Status: COMPLETED ·Phase: PHASE4

A Study To Investigate The Absorption, Metabolism And Excretion Of [14C] PD 0200390 In Six Healthy Male Volunteers

NCT00722306 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of Ramelteon in Healthy Subjects

NCT00671190 ·Status: COMPLETED ·Phase: PHASE2

A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia

NCT03542851 ·Status: UNKNOWN ·Phase: PHASE2

Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL

NCT00236080 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Daridorexant in Participants With Insomnia Disorder

NCT07028697 ·Status: COMPLETED ·Phase: PHASE3

Late Phase II Study of TS-142 in Patients with Insomnia

NCT04469023 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury

NCT00893789 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work Disorder

NCT01080807 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression

NCT00518986 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder

NCT02841709 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia

NCT06843590 ·Status: RECRUITING ·Phase: PHASE2

Efficacy, Safety and Tolerability of Sulthiame in Patients With Obstructive Sleep Apnea (OSA)

NCT05236842 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy

NCT05059223 ·Status: COMPLETED ·Phase: PHASE3

Repurposing Dexmedetomidine as an Orally Administered Sleep Therapeutic

NCT02818569 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety/Efficacy Study With Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Chronic SWSD

NCT00080288 ·Status: COMPLETED ·Phase: PHASE3

Long-Term Study of TS-142 in Patients with Insomnia

NCT05461352 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study B (MK-4305-029)

NCT01097629 ·Status: COMPLETED ·Phase: PHASE3

Sleepiness and Brain Function: The Effect of Armodafinil in Shift Work Sleep Disorder

NCT00688142 ·Status: COMPLETED

A Long Term Safety Study of Suvorexant in Participants With Primary Insomnia (MK-4305-009 AM3)

NCT01021813 ·Status: COMPLETED ·Phase: PHASE3